Commission Delegated Regulation (EU) 2016/161 ANNEX IV

ANNEX IVSupplementary provisions

ANNEX IV Notification to the European Commission of medicinal products judged not to be at risk of falsification , pursuant to article 54a(4) of Directive 2001/83/EC Member State: Name of competent authority:   Entry No Active substance (Common Name) Pharmaceutical form Strength Anatomical Therapeutical Chemical (ATC) Code Comments/Complementary information 1           2           3           4           5           6           7           8           9           10           11           12           13           14           15           Note: The number of entries is not binding.